Section I
4321 – 4330 of 4892
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Chemoradiotherapy of esophageal cancer.
(
- Contribution to journal › Scientific review
-
Mark
Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum
(
- Contribution to journal › Article
-
Mark
Variation in BRCA1 cancer risks by mutation position
(
- Contribution to journal › Article
-
Mark
Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer.
(
- Contribution to journal › Article
-
Mark
Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C.
(
- Contribution to journal › Article
-
Mark
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 8377 breast cancer patients
(
- Contribution to journal › Article
-
Mark
Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy
(
- Contribution to journal › Article
-
Mark
Integrins in invasive growth.
(
- Contribution to journal › Article
-
Mark
Predominance of CIN versus MSI in the development of rectal cancer at young age.
(
- Contribution to journal › Article